| Phase 3 |
| NCT07211009 |
Patient-Reported Symptom Care Versus Usual Care After Esophageal Cancer Surgery: A… |
Esophageal Cancer (EsC) |
Not Yet Recruiting |
| Phase 2 |
| NCT06111625 |
Short-term Blinatumomab as a Bridge Therapy for Allo-HSCT in Low Burden B-ALL |
Leukemia, Lymphoid |
Recruiting |
| NCT06403878 |
Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable… |
Esophageal Cancer |
Recruiting |
| NCT06675201 |
Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma |
Esophageal Squamous Cell Carcinoma (ESCC) |
Recruiting |
| NCT06603402 |
Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC |
Esophageal Squamous Cell Carcinoma (ESCC) |
Recruiting |
| NCT06769295 |
A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in… |
Lung Cancer, Non-Small Cell |
Recruiting |
| NCT06769971 |
Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in… |
Small Cell Lung Cancer |
Recruiting |
| NCT06446726 |
Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous… |
Esophageal Squamous Cell Carcinoma |
Recruiting |
| NCT07014943 |
High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous… |
Primary Central Nervous System Lymphoma (PCNSL) |
Recruiting |
| NCT06951464 |
A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC |
Non-Small Cell Lung Cancer |
Recruiting |
| NCT06121505 |
Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab +… |
Lung Squamous Cell Carcinoma |
Recruiting |
| NCT06877299 |
Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB… |
Lung Cancer |
Recruiting |
| NCT06610734 |
Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With… |
Small Cell Lung Cancer Extensive Stage |
Recruiting |
| NCT07519486 |
Intensive Nutritional Support in Conversion Therapy for Locally Advanced Unresectable ESCC |
Esophageal Squamous Cell Carcinoma |
Recruiting |
| NCT07748325 |
Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant… |
Non-Small Cell Lung Cancer |
Recruiting |
| NCT05186506 |
A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for… |
ALK Fusion Protein Expression |
Not Yet Recruiting |
| NCT06075225 |
MAP-guided Preemptive Therapy of aGvHD by Ruxolitinib |
GVHD |
Not Yet Recruiting |
| NCT06075238 |
Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCT |
Leukemia, Lymphoid |
Not Yet Recruiting |
| NCT06213519 |
HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With… |
Peritoneal Metastases |
Not Yet Recruiting |
| NCT06883552 |
An Open-label, Single-arm Clinical Study of Stapokibart Injection in Combination with… |
Lung Cancer (NSCLC) |
Not Yet Recruiting |
| NCT07374250 |
Perioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or… |
Gastric Cancer |
Not Yet Recruiting |
| NCT07501169 |
Sacituzumab Tirumotecan in Combination With Anlotinib in Previously Treated Patients With… |
Extensive-stage Small Cell Lung Cancer (ES-SCLC) |
Not Yet Recruiting |
| NCT05765825 |
Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With… |
Extensive-stage Small-cell Lung Cancer |
Active, Not Recruiting |
| NCT07258147 |
Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC… |
Lung Cancer (SCLC) |
Not Yet Recruiting |
| NCT07658872 |
Perioperative Fruquintinib Combined With Sintilimab and SOX for Locally Advanced Gastric… |
Gastric Adenocarcinoma |
Not Yet Recruiting |